• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine . Measuring the impact of influenza vaccination in the Netherlands using retrospective observational primary care, hospitalisation and morta

tetano

Editor, Senior Moderator
Vaccine


. 2024 Sep 14;42(26):126244.
doi: 10.1016/j.vaccine.2024.126244. Online ahead of print. Measuring the impact of influenza vaccination in the Netherlands using retrospective observational primary care, hospitalisation and mortality data

Marianne J Heins[SUP] 1 [/SUP], Peter Spreeuwenberg[SUP] 1 [/SUP], Saverio Caini[SUP] 1 [/SUP], Mariëtte Hooiveld[SUP] 2 [/SUP], Adam Meijer[SUP] 3 [/SUP], John Paget[SUP] 1 [/SUP]



Affiliations
Free article Abstract

We aimed to estimate the impact of influenza vaccination in the Netherlands using general practitioner medical records for 2011-2020. We found that vaccinees had higher consultation rates for influenza-like-illness, acute respiratory infections, and pneumonia, as well as antibiotic use, hospitalisations, and several control diagnoses (i.e. illnesses for which there was no a priori expectation that influenza vaccination would play a protective effect). We found similar rates for respiratory mortality and lower all-cause mortality in the vaccinees versus non-vaccinees, mainly driven by the 75+ age group. These results expand, but are fairly consistent with those of previous investigations, and highlight the difficulty of using registry data to assess the impact of vaccination, because of underlying differences between vaccinees and non-vaccinees. Whether these biases also play a role for hospitalisations and mortality remains unclear. Our findings support the implementation of randomized studies to assess the impact of influenza vaccination.

Keywords: Bias; Health outcomes; Influenza; Observational data; Vaccination.

 
Back
Top Bottom